← Leaderboards
Jeremiah D Momper
University Of California, San Diego
$1,201,557
Attributed
$1,389,285
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $346.5K · FY2020–25$500K$375K$250K$125K$0
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$1,389,285 · 2
By mechanism
P50$1,013,829 · 1
R21$375,456 · 1
Top collaborators
- Timothy Roy Cressey2 shared
Most similar at University Of California, San Diego
Same institution · by research overlap
- Adriana H Tremoulet$8,401,727
- Victor Nizet$31,303,620
- Shirley M Tsunoda$1,176,383
- Stephen A Spector$131,199,154
- Scott L Letendre$25,948,231
Others in their field
Other Emerging Leaders on “Physiological”
- Evan Z Macosko · Broad Institute, Inc.$28,857,317
- Hemali Phatnani · New York University School Of Medicine$20,806,518
- Robyn Lorraine Woods · Hennepin Healthcare Research Institute$19,109,927
- Niels Kuster · It'Is Foundation$15,289,991
- Rachana Agarwal · Leidos Biomedical Research, Inc.$15,241,462
- Xinhua Li · Nano Terra, Inc.$14,470,585
Research focus
PhysiologicalPharmacokinetic ModelSamplingDrug KineticsMothersParentsPharmaceutical PreparationsPlasmaInfrastructureInnovationHigh Pressure Liquid ChromatographyEducation And OutreachEnvironmentHair Shaft StructureAnalytical ChemistryHuman MilkKnowledge AcquisitionBloodData ScienceAntibioticsBasic ScienceBreastfed InfantBreast FeedingCoupled
Grant awards (7)
Pharmacometrics and Analytical Chemistry Core$202,243
P50 · FY2025 · HD · contact PI
Pharmacometrics and Analytical Chemistry Core$202,561
P50 · FY2024 · HD · contact PI
Pharmacometrics and Analytical Chemistry Core$203,281
P50 · FY2023 · HD · contact PI
Pharmacometrics and Analytical Chemistry Core$200,597
P50 · FY2022 · HD · contact PI
Pharmacometrics and Analytical Chemistry Core$205,147
P50 · FY2021 · HD · contact PI
Enhanced maternal and fetal PBPK models to predict drug exposures of novel oral and long-acting antivirals during pregnancy$141,393
R21 · FY2021 · HD · contact PI
Enhanced maternal and fetal PBPK models to predict drug exposures of novel oral and long-acting antivirals during pregnancy$234,063
R21 · FY2020 · HD · contact PI